4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-(5021-54-5)
- Name: 4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
- Synonyms:
- Molecular Formula:C20H18N2S
- Molecular Weight:
- CAS Registry Number:5021-54-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.5021-54-5 4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
Assay:99% Appearance:powder or liquid Package:according to customer requirements Storage:store in dry dark and ventilated place Transportation:By Sea/Air/Courier Application:It is an important raw material.
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.5021-54-5 1,2-Diphenyl-5,6,7,8-tetrahydroquinazoline-4(1H)-thione
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.5021-54-5 4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
Assay:95% Application:Synthetic building block
Min. Order:0
Supplier:SAGECHEM LIMITED [
China (Mainland)] CAS No.5021-54-5 4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 502150-56-3/Pyridazinium, 3-methyl-, 1-[1-[[(4-chlorophenyl)amino]carbonyl]-2-(4-nitrophenyl)-2-oxoethylide]
- 502150-67-6/1,5,9,11-Cyclotetradecatetraene-1-carboxaldehyde, 5,9-dimethyl-12-(1-methylethyl)-, (1Z,5E,9E,11E)-
- 502150-72-3/Silane, [[(2E)-3-(4-methoxyphenyl)-1-methylene-2-propenyl]oxy]trimethyl-
- 502150-74-5/Methanesulfonamide, N-(2-methoxyethyl)-N-[4,4,6,6-tetramethyl-2-[[2-methyl-6-(trifluoromethyl )-3-pyridinyl]carbonyl]-3,5-dioxo-1-cyclohexen-1-yl]-
- 502150-75-6/Ethanesulfonamide, N-(2-methoxyethyl)-N-[4,4,6,6-tetramethyl-2-[[2-methyl-6-(trifluoromethyl )-3-pyridinyl]carbonyl]-3,5-dioxo-1-cyclohexen-1-yl]-
- 502150-76-7/Methanesulfonamide, N-(2-methoxyethyl)-N-[3-[[2-methyl-6-(trifluoromethyl)-3-pyridinyl]carbon yl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl]-
- 502150-77-8/Ethanesulfonamide, N-(2-methoxyethyl)-N-[3-[[2-methyl-6-(trifluoromethyl)-3-pyridinyl]carbon yl]-4-oxobicyclo[3.2.1]oct-2-en-2-yl]-
- 502150-81-4/Ethanesulfonamide, N-(2-methoxyethyl)-
- 502150-93-8/Silane, (1,1-dimethylethyl)dimethyl[[1-(2-propynyl)undecyl]oxy]-
- 502150-94-9/Silane, (1,1-dimethylethyl)[[1-[(2E)-3-iodo-2-propenyl]undecyl]oxy]dimethyl-
- 502150-95-0/Silane, [[(3E)-1-decyl-3-undecen-5-ynyl]oxy](1,1-dimethylethyl)dimethyl-
- 502150-96-1/Silane, [[(3E,5Z)-1-decyl-3,5-undecadienyl]oxy](1,1-dimethylethyl)dimethyl-
- 502150-97-2/1-Tetradecyn-4-ol
- 502152-37-6/1H-Indazole, 3-(1H-pyrrol-2-yl)-
- 502152-39-8/1H-Indazole, 3-(1H-indol-3-yl)-
- 502152-42-3/1H-Indazole, 3-(2-thienyl)-
- 502152-46-7/1H-Indazole, 3-[1-(4-morpholinylmethyl)-1H-pyrrol-2-yl]-
- 502152-48-9/1H-Indazole, 1-(4-morpholinylmethyl)-3-[1-(4-morpholinylmethyl)-1H-indol-2-yl]-
- 502152-61-6/Benzene, 1-methoxy-4-[2-(trans-4-pentylcyclohexyl)ethenyl]-
- 5021-54-5/4(1H)-Quinazolinethione, 5,6,7,8-tetrahydro-1,2-diphenyl-
- 502156-27-6/Carbamic acid, [7-[[2-[[(4-nitrophenyl)sulfonyl]amino]ethyl]amino]heptyl]-, 1,1-dimethylethyl ester
- 502156-85-6/9H-Pyrido[3,4-b]indol-3-amine, 4-ethyl-9-(1-methylethyl)-
- 502156-86-7/9H-Pyrido[3,4-b]indole-3-carboxylic acid, 4-ethyl-9-(1-methylethyl)-, ethyl ester
- 502156-87-8/9H-Pyrido[3,4-b]indole-3-carboxylic acid, 9-(1-methylethyl)-
- 502156-88-9/9H-Pyrido[3,4-b]indole-3-carboxylic acid, 4-ethyl-9-(1-methylethyl)-
- 502156-89-0/Carbamic acid, [4-ethyl-9-(1-methylethyl)-9H-pyrido[3,4-b]indol-3-yl]-, 2-(trimethylsilyl)ethyl ester
- 502156-93-6/Piperazine, 1-[3-(2-formyl-4,5,6,7-tetrahydro-1H-indol-3-yl)-1-oxopropyl]-3,5-dimeth yl-
- 502156-95-8/Piperazine, 1-[3-(2-formyl-4,5,6,7-tetrahydro-1H-indol-3-yl)-1-oxopropyl]-4-methyl-
- 502156-96-9/Piperazine, 1-[3-[2-[(Z)-[5-(ethylsulfonyl)-1,2-dihydro-2-oxo-3H-indol-3-ylidene]meth yl]-4,5,6,7-tetrahydro-1H-indol-3-yl]-1-oxopropyl]-3,5-dimethyl-
- 502156-97-0/1H-Indole-5-sulfinic acid, 2,3-dihydro-2-oxo-, zinc salt (2:1)